Natural Alternatives Internatio (NAII) Fair Value 2026

NAII · Medicinal Chemicals & Botanical Products ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.2 /10

32 fundamental signals · 10 models active

Value Trap Risk

LOW (30/100)

Quick Summary — As of 2026-07-13, Natural Alternatives Internatio (NAII) trades at $2.21. QOC: 6.2/10. Value Trap Risk: 30/100 (LOW). 10/13 models active.

Key Facts

Ticker
NAII
Price
$2.21
Quality Score
6.2/10
Value Trap Risk
30/100
Models Active
10/13
Last Updated
Strength: CUCE Ensemble suggests +341.2% upside with 6% confidence
Risk: Limited model coverage (10/13) may reduce confidence

Valuation Matrix

10 Intrinsic Value Models vs. Current Price ($2.21)

Core Models (Unlocked)
Model Fair Value Upside
Earnings Power Value
High Conviction
$8.77 +296.6%
CUCE Ensemble
Low Conviction
$9.75 +341.2%
First Chicago
High Conviction
$8.69 +293.2%
Dynamic NAV
High Conviction
$7.19 +225.5%

Unlock the Full Matrix

Access 6 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 10 Models →

Cancel anytime · No contracts · Instant access

What Is Natural Alternatives Internatio (NAII) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Natural Alternatives Internatio's intrinsic value is estimated at a composite fair value of $6.77. At a current market price of $2.21, 8 of 10 active valuation models identify upside potential, projecting an average implied return of +206.3%. Notably, CUCE sees the most upside at +341.2% (fair value: $9.75), while Markov DDM is the most conservative at -88.0% ($0.26). The spread between these extremes — +429.2% — reveals how different analytical frameworks can reach starkly different conclusions. Among models with highest confidence, EPV lean bullish — adding weight to the bullish side of the thesis.

What Do the Models Say About NAII?

10 of 13 models are currently active for NAII. Of these, 8 models suggest upside while 2 models suggest overvaluation. See which stocks rank higher →

How Does NAII Rank in Medicinal Chemicals & Botanical Products?

Among 17 Medicinal Chemicals & Botanical Products stocks, NAII ranks #7 by Quality of Company score. CirclFi's QOC score of 6.2/10 evaluates 32 fundamental signals. A score of 6.2 indicates above-average quality.

As a manufacturing company, Natural Alternatives Internatio operates in a sector where organic revenue growth is a critical driver of valuation. Investors evaluating NAII should weigh these sector-specific dynamics alongside our model-derived fair values.

Is NAII a Value Trap?

CirclFi's Value Trap algorithm assigns NAII a score of 30/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

10 of 13 models are active for Natural Alternatives Internatio. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Natural Alternatives Internatio's fundamental quality profile registers 6.2/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +429.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every NAII valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across NAII's 10 active models, average confidence is 39%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Natural Alternatives Internatio Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medicinal Chemicals & Botanical Products Stocks Should You Also Analyze?

8 related Medicinal Chemicals & Botanical Products stocks with 13-model coverage

Read investment analysis: NAGE · FTLF · USNA · BTMD · TLRY

Frequently Asked Questions About Natural Alternatives Internatio

What is Natural Alternatives Internatio's intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Natural Alternatives Internatio (NAII) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value. The Quality of Company score is 6.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is NAII overvalued or undervalued right now?

At $2.21, 8 of 10 active models suggest NAII may be undervalued, while 2 indicate potential overvaluation. The assessment depends on which methodology best fits Natural Alternatives Internatio's business model in Medicinal Chemicals & Botanical Products.

What does a Quality of Company score of 6.2 mean for NAII?

Natural Alternatives Internatio's QOC of 6.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on NAII?

CirclFi analyzes NAII with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 10 of 13 are active for this stock. Read the full methodology →

Is NAII a value trap in 2026?

Natural Alternatives Internatio's Value Trap score is 30/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 10 mathematical frameworks give you clarity on NAII.

Unlock All 10 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access